Reflecting on my Penta-supported time at the SRHR conference

Beyond the prescription: How food, formulation and timing can affect drug efficacy

Gabapentin as an add-on analgesic to morphine in paediatric patients with chronic pain

HIV-1 Drug Resistance in Mother–Infant Pairs in Southern Mozambique

Penta Young Reporters at the 10th International Workshop on Adolescence, SRHR & HIV 2026

Switch to injectable cabotegravir–rilpivirine given every 8 weeks in adolescents living with HIV with virological suppression in sub-Saharan Africa (LATA): a randomised, open-label, multicentre, 96-week non-inferiority trial

Strengthening paediatric HIV care in Zimbabwe: THRIVE AHD training workshop in Kadoma

New evidence from NeoIPC study supports the case for unit-wide infection prevention in Europe’s neonatal units

External controls in paediatric HIV trials: frequentist and Bayesian approaches

A comparison of different borrowing approaches in a trial evaluating therapy in HIV-infected children

Missing viral load measurements in HIV treatment trials: a comparison of approaches

TEAM-COACH Project concludes with strong results and ambitious plans for international expansion

Neonatal Unit Colonization Pressure and Acquisition of Extended-Spectrum β-Lactamase Gut Colonization

Temporal, seasonal, and spatial patterns of Mpox in the DRC, 2002-2022: longitudinal surveillance study

Impact of in utero exposure to SARS-CoV-2 on children’s hospital admission: a national birth cohort study in England

Expediting a UNIVERSAL first-line regimen of a dolutegravir–emtricitabine–tenofovir alafenamide fixed-dose ratio for children living with HIV older than 4 weeks: a 24-week, open-label, single-arm, phase 1–2, pharmacokinetic, safety, and antiviral activity trial

Making older antibiotics work safely for children with sepsis. An interview with the SNIP-AFRICA team

Children must not be left behind in Bundibugyo virus disease research, Penta experts warn